Altimmune, Inc.ALTNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank86
5Y CAGR+20.6%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

5Y CAGR
+20.6%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
2.6x
Strong expansion
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025105.00%
2024-95.31%
2023726.47%
2022-101.54%
2021-46.12%
202041.09%
2019-43.85%
201824792.58%
2017-99.21%
2016-50.85%